Nektar Therapeutics - NKTR - stock price prediction, stock price target, analyst ratings from 8 analysts

Nektar Therapeutics has a share price target of US$ 104, revenue growth forecast of -57.1%, and profit growth estimate of -53.3% for FY25, based on top 8 analyst calls.